Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This meta-analysis compared the metabolic effects of different vitamin D formulations in patients with obesity-associated MetS.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis

Source: Article title.

This study was a systematic review and meta-analysis of previously published randomized controlled trials.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis

Systematic review · Medicine · 2026

Original publication title

Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis

Qin Huang; Jidong Zhan; Yuan Gui; Ming Ma; E. Li

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In obesity-associated MetS, vitamin D3 and active vitamin D, particularly at higher doses and longer durations, are associated with reductions in visceral fat and improvements in glycemic control, insulin resistance, and selected lipid indices; vitamin D2 appears less effective.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Obesity-associated metabolic syndrome (MetS) is characterized by abdominal adiposity, insulin resistance, and dyslipidemia. Vitamin D deficiency is prevalent in obesity, and supplementation has been hypothesized to modulate body fat distribution and glucolipid metabolism. This meta-analysis compared the metabolic effects of different vitamin D formulations in patients with obesity-associated MetS.

Source: Background:

Abstract: What methods does the paper describe?

PubMed, EMBASE, Cochrane Library, Web of Science, and CNKI were searched from inception to the search date. Randomized controlled trials enrolling patients with obesity and/or MetS and evaluating vitamin D2, vitamin D3, or active vitamin D versus placebo/no intervention/low-dose vitamin D for ≥8 weeks were included. Primary outcomes were visceral and subcutaneous fat indices; secondary outcomes included fasting glucose, homeostatic model assessment of insulin resistance, and lipid parameters. Effect sizes were pooled as mean difference (MD) or standardized mean difference (SMD) with 95% confidence intervals (CIs); heterogeneity was assessed using I2.

Source: Methods:

Abstract: Results

Fifty randomized controlled trials were included. Vitamin D3 and active vitamin D reduced visceral adiposity (SMD −0.35, 95% CI: −0.50 to −0.20; and −0.40, 95% CI: −0.60 to −0.20; I2 = 42%), whereas vitamin D2 showed no significant effect (SMD −0.10, 95% CI: −0.25 to 0.05). Vitamin D3 and active vitamin D improved fasting glucose (MD −0.30 and −0.35 mmol/L) and homeostatic model assessment of insulin resistance (SMD −0.40 and −0.45), and lowered LDL (MD −0.30 and −0.25 mmol/L).

Benefits were greater with ≥2000 IU/d, intervention duration ≥6 months, and baseline 25(OH)D <20 ng/mL. The Egger test did not indicate significant publication bias (P = .12).

Source: Results:

Abstract: Conclusions

In obesity-associated MetS, vitamin D3 and active vitamin D, particularly at higher doses and longer durations, are associated with reductions in visceral fat and improvements in glycemic control, insulin resistance, and selected lipid indices; vitamin D2 appears less effective.

Source: Conclusions:
Authors’ abstract

Background:

Obesity-associated metabolic syndrome (MetS) is characterized by abdominal adiposity, insulin resistance, and dyslipidemia. Vitamin D deficiency is prevalent in obesity, and supplementation has been hypothesized to modulate body fat distribution and glucolipid metabolism. This meta-analysis compared the metabolic effects of different vitamin D formulations in patients with obesity-associated MetS.

Methods:

PubMed, EMBASE, Cochrane Library, Web of Science, and CNKI were searched from inception to the search date. Randomized controlled trials enrolling patients with obesity and/or MetS and evaluating vitamin D2, vitamin D3, or active vitamin D versus placebo/no intervention/low-dose vitamin D for ≥8 weeks were included. Primary outcomes were visceral and subcutaneous fat indices; secondary outcomes included fasting glucose, homeostatic model assessment of insulin resistance, and lipid parameters. Effect sizes were pooled as mean difference (MD) or standardized mean difference (SMD) with 95% confidence intervals (CIs); heterogeneity was assessed using I2.

Results:

Fifty randomized controlled trials were included. Vitamin D3 and active vitamin D reduced visceral adiposity (SMD −0.35, 95% CI: −0.50 to −0.20; and −0.40, 95% CI: −0.60 to −0.20; I2 = 42%), whereas vitamin D2 showed no significant effect (SMD −0.10, 95% CI: −0.25 to 0.05). Vitamin D3 and active vitamin D improved fasting glucose (MD −0.30 and −0.35 mmol/L) and homeostatic model assessment of insulin resistance (SMD −0.40 and −0.45), and lowered LDL (MD −0.30 and −0.25 mmol/L).

Benefits were greater with ≥2000 IU/d, intervention duration ≥6 months, and baseline 25(OH)D <20 ng/mL. The Egger test did not indicate significant publication bias (P = .12).

Conclusions:

In obesity-associated MetS, vitamin D3 and active vitamin D, particularly at higher doses and longer durations, are associated with reductions in visceral fat and improvements in glycemic control, insulin resistance, and selected lipid indices; vitamin D2 appears less effective.

Publication and source details

Original title: Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis

Qin Huang; Jidong Zhan; Yuan Gui; Ming Ma; E. Li

Medicine · 2026

* Correspondence: E. Li, Department of General Medicine, The Hospital of Huazhong University of Science and Technology, Wuhan City 430074, Hubei Province, China (e-mail: 1470048212@qq.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:57:05.125549+00:00

DOI: 10.1097/md.0000000000047436 · PMC12928931